Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study investigated the combined impact of rituximab and targeted nursing care versus tacrolimus and targeted nursing care on efficacy, quality of life, adverse reactions, and recurrence rate in children with challenging (steroid-dependent or frequently relapsing) nephrotic syndrome. Ninety-one pediatric patients were randomized to either receive rituximab plus targeted nursing or tacrolimus plus targeted nursing, and outcomes were assessed over a 6-month period.
Epistemonikos ID: 4ed6ac9a3274b56afd386cc3defe0cc152d4d7e5
First added on: Jul 04, 2025